NCT05092373
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Breast Carcinoma, +110 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Metastatic Endometrial Carcinoma
Explore clinical trials studying Metastatic Endometrial Carcinoma. Study availability and eligibility vary by location and protocol.
11 public trials
4 recruiting studies
Metastatic Endometrial Carcinoma trial results
NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT06586957
- Conditions
- Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
- Locations
-
- University of Arkansas Medical School Little Rock, Arkansas, United States
- University of California - Los Angeles Los Angeles, California, United States
- UCSF San Francisco, California, United States
- SCRI at HealthOne Denver, Colorado, United States
Recruiting
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
- Locations
-
- Mayo Clinic in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Not Yet Recruiting
A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors
NCT07715747
- Conditions
- Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, +25 more
- Locations
-
- Shanghai GoBroad Cancer Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
NCT07634601
- Conditions
- Advanced Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +14 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
NCT03508570
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +58 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer
NCT03120624
- Conditions
- Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +19 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, Not Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
NCT04704661
- Conditions
- Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
Active, Not Recruiting
Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer
NCT03367741
- Conditions
- Advanced Endometrial Carcinoma, Carcinosarcoma, Endometrial Neoplasms, +19 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States